secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oscar Health, Inc. (OSCR)
CIK:        0001568651
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001568651-24-000029
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oscar Health Q3 revenue $2.4B (+68% YoY); narrows loss; raises FY revenue guidance
--------------------------------------------------------------------------------

- Total revenue $2.4B, +68% YoY; net loss $54.6M ($0.22 EPS) improved $10.8M YoY.
- Membership grew to 1.65M from 983k YoY, driven by Individual and Small Group (1.60M).
- Adjusted EBITDA loss $11.6M, improved $8.7M YoY; SG&A expense ratio improved to 19.0% from 22.6%.
- FY2024 revenue guidance raised to $9.2-9.3B; expects net income profitability this year.
- Medical Loss Ratio 84.6%, up 80bps YoY due to higher medical costs and risk adjustment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1568651/000156865124000029/0001568651-24-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1568651/000156865124000029/oscr-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001568651-24-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer